Early reports suggest symptom benefits may persist 3–6 months following a single injection or infusion. Several studies indicate waning effect by month 9, prompting discussion of repeat dosing, though no standardised retreatment protocols have been established. Durability data derive from observational follow-up rather than controlled extension studies. Long-term (12+ month) outcomes are sparse.
The menopausal transition involves profound shifts in oestrogen and progesterone levels, triggering vasomotor symptoms such as hot flushes and night sweats, alongside mood changes, sleep disruption, and vaginal dryness. Whilst conventional hormone replacement therapy addresses many symptoms, some women seek or require alternatives. Regenerative medicine approaches—particularly placental-derived exosomes and mesenchymal stem cells—are being studied as potential supplements to traditional management, with interest centred on whether these agents might support natural hormonal regulation and tissue repair. Current research remains exploratory, focused on mechanisms rather than clinical equivalence to established treatments.
Am I a candidate? → · Menopause & Hormonal Health: full overview → · Menopause & Hormonal Health cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Dr Dmytro Stoyanov (Urologist · 31+ yrs clinical practice) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
Medicina regenerativa certificada GMP en el corazón de la UE — desde 3.000–8.000 €, una fracción de los precios de EE. UU. o Alemania. Protocolos personalizados para pacientes de más de 50 países.
Evaluación médica gratuita